---
title: "9 Meters Biopharma, Inc. (NMTRQ.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/NMTRQ.US.md"
symbol: "NMTRQ.US"
name: "9 Meters Biopharma, Inc."
industry: "Pharmaceuticals"
---

# 9 Meters Biopharma, Inc. (NMTRQ.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.9meters.com](https://www.9meters.com) |

## Company Profile

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucago...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2023-07-24T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/NMTRQ.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/NMTRQ.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/NMTRQ.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.